INTRODUCTION
============

Cardiovascular magnetic resonance imaging (CMR) is expected to be increasingly used in Korea due to the progress in its underlying technology and the expansion of the national insurance system to cover CMR assessments. To define the proper indications for cardiac imaging in clinical practice, the Korean Society of Cardiovascular Imaging (KOSCI) and the Korean Society of Cardiology jointly published appropriate use criteria for CMR and cardiac computed tomography (CT), and the Asian Society of Cardiovascular Imaging also published multimodality appropriate use criteria for noninvasive cardiac imaging ([@B1][@B2][@B3]). To ensure that CMR can effectively improve patient care, it is crucial to not only acquire the images properly but also to ensure that the results are accurately interpreted by well-trained personnel. In response to the increased demand for the use of CMR, KOSCI released CMR interpretation guidelines in conjunction with the Korean Society of Radiology and established a committee on CMR guidelines. The members of this committee meet to review previously published interpretation guidelines and discuss the patterns of CMR use in Korea. In addition, the committee surveys cardiologists and cardiac surgeons at academic hospitals who utilize CMR in their clinical practice. The purpose of these surveys is to investigate the results these clinicians are seeking from CMR examinations in each clinical scenario.

These interpretation guidelines devised by KOSCI are divided into two parts: "anatomy and cardiac function" and "myocardial tissue characterization." The anatomy and cardiac function section includes cine magnetic resonance imaging (MRI), flow imaging, and angiography. Cine MRI has been known as the gold standard for ventricular functional analysis and, with recent advances in MRI and CT, studies comparable to cine MRI have been reported ([@B4][@B5][@B6]). In addition, studies have been carried out to estimate the prognosis of the disease by measuring myocardial strain using cine MRI, and to evaluate the left atrial volume in patients with atrial fibrillation by using three-dimensional (3D) CMR ([@B7][@B8][@B9]). Myocardial tissue characterization includes studies assessing perfusion, delayed enhancement, and T1 and T2 mapping. Recently, many articles on myocardial tissue characterization and quantification have been published ([@B10][@B11][@B12][@B13][@B14]). These CMR guidelines cover cardiovascular diseases that occur mainly in adults and congenital heart disease in adult patients. Each module of the guidelines describes visual and quantitative assessments separately. Although not all modules require quantitative assessment (e.g., perfusion MR), this is sometimes necessary, as in the case of T1 and T2 mapping. Each assessment method is divided into "what-to-see," "how-to," and "pitfalls." For a typical indication of CMR (e.g., ischemic heart disease, cardiomyopathy, postoperative tetralogy of Fallot \[TOF\]), a sample report with representative images is also presented so that even a novice reader can refer to it in their clinical practice. These guidelines reflect the consensus of committee members who participated in their writing and are therefore not absolute. We believe that they can be used appropriately in accordance with each hospital situation and clinical scenario. More rare and specific indications such as coronary angiography or complex congenital heart disease were not included in these guidelines. The guidelines will be updated as CMR technology continues to evolve and the analysis software advances. It is hoped that they will help to standardize CMR interpretation in the future and improve the quality of care for cardiac patients.

Left Ventricular Functional Assessment
======================================

Visual Assessment
-----------------

### I. What-to-see

1\. Anatomy of the left ventricle (LV), left ventricular outflow tract (LVOT), and aortic root can be evaluated using cine images.2. Global and segmental motion of the LV can be assessed.3. Hemodynamic information such as shunt flow, valvular stenosis or regurgitation, flow acceleration at the LVOT, and evidence of constrictive physiology can be assessed.

### II. How-to

1\. Check all cine images, validate using different planes, and evaluate the presence of artifacts.2. LV function is evaluated in terms of global and segmental aspects, and segmental wall motion is evaluated based on the segmental wall thickness at systole. The evaluation uses the standard LV segmentation nomenclature ([Fig. 1](#F1){ref-type="fig"}) ([@B15]). Wall motion is classified as hyperkinetic, normokinetic, hypokinetic, akinetic, or dyskinetic ([@B16]).

Quantitative Assessment
-----------------------

### I. What-to-see

1\. Measured LV parameters are as follows: end-diastolic (ED) volume, end-systolic (ES) volume, ejection fraction (EF), stroke volume (SV), cardiac output (CO), and LV mass, including both measured and body surface area (BSA)-indexed values.

### II. How-to

#### 1. General

A. Evaluate the stack of short-axis cine images using computer analysis software.B. Acquire contours of endocardial and epicardial borders at both the ED and ES phases ([Fig. 2](#F2){ref-type="fig"}).C. If a chemical shift artifact occurs, the epicardial border is drawn in the middle of the chemical shift artifact line ([@B17]).D. LV ED and ES images are acquired at the largest and the smallest LV blood volume, respectively.E. The reader must check the appropriateness of automatic contour delineation (when used).

#### 2. LV volumes

A. Papillary muscles should be included with the myocardium. However, some evaluation tools do not draw its contour, but rather recognize it as a chamber volume. Inclusion or exclusion of papillary muscles should be mentioned ([@B18][@B19]).B. LVOT should be included as the part of LV blood volume. The drawing contour should be included in the outflow tract to the level of the aortic valve cusps.C. Because of the tendency of the mitral valve to apex in the systole phase (the so-called basal descent), assessing the basal slice requires caution during evaluation. If the blood volume surrounded by the myocardium in the basal slice is less than 50%, this space is considered to be the left atrial cavity. Some evaluation tools automatically check the systolic atrioventricular ring descent.

#### 3. LV mass

A. Calculation: (Total epicardial volume - total endocardial volume) × specific density of the myocardium (1.05 g/mL) ([@B17]).B. Papillary muscles are myocardial tissue and should be included, particularly in cases of myocardial hypertrophy. The inclusion or exclusion of papillary muscles should be mentioned ([@B18]).C. Base and apex: Most basal slices contain a small crescent of basal lateral myocardium without ventricular blood volume, and this myocardium should be included in the LV mass. In addition, most apical slices may contain myocardium without a blood cavity, and the epicardial contour should be considered for LV mass evaluation.

#### 4. Quick assessment

A. In the absence of significant regional variations, a quick calculation can be performed without the use of analysis software.B. A rotational long-axis view (e.g., 2-chamber and 4-chamber views) allows for faster evaluation and is not limited by basal descent. The assessment technique should be mentioned in the report.C. Calculation1) In general, two calculation formulae are used ([@B20][@B21]), as indicated below.2) A single long-axis equation: LV volume = 0.85 × (LV~area~)^2^ / LV~length~. This is performed using a 4-chamber view. The calculation requires both ED and ES phases. The LV~area~ is a straight line connecting the endocardial contour of the medial and lateral portions of the base. The LV~length~ is the length from the base to the endocardial border of the apex.3) A biplane equation: LV volume = 0.85 × (LV~area1~ × LV~area2~) / LV~length~. Both 4-chamber and 2-chamber views are used, similar to the single long-axis equation, except that both the LV~area1~ and LV~area2~ are measured in each view, respectively.D. The cavity diameter and LV wall thickness can be obtained as follows ([@B22]).1) For measurements in a short-axis image, measure at the base just below the papillary muscle tip.2) In a 3-chamber image, measurements are made on the LV minor axis plane showing the mitral cordae at the base of the papillary muscle tip.3) Both methods have good reproducibility, and the 3-chamber method is the most comparable to echocardiography.

### III. Pitfalls

1\. If there is an alteration in the axis of the cine image due to a disease that can cause structural changes in the heart (e.g., valvular or ischemic heart disease), it is necessary to confirm whether measurement of the axis is appropriate.2. If the cine image does not contain sufficient LV apex and base, the measured value may be incorrect.3. If the cine slice thickness or gap is large, the measured value may be inaccurate. It is recommended that the slice thickness and gap should be kept within 10 mm.

Reporting
---------

### I. Visual assessment

1\. EvaluationA. Sufficient/insufficient (if insufficient, describe below)1) Lack of image/insufficient field of view (FOV)/artifact/etc. ( )2. Wall motionA. Global/segmental (if present, describe location: )B. Hyperkinetic/normal/hypokinetic/akinetic/dyskinetic3. Hemodynamic interaction between LV and right ventricle (RV)A. Absent/present (if present, describe )

### II. Quantitative assessment

1\. MethodA. Standard/quick (single long-axis/biplane)2. Papillary muscle asA. Myocardial mass/ventricular cavity3. EF: %4. End-diastolic volume (EDV): mL ( mL/m^2\*^)5. End-systolic volume (ESV): mL ( mL/m^2\*^)6. SV: mL ( mL/m^2\*^)7. CO: L/min8. Cardiac index (CI): L/min/m^2\*\*^BSA-indexed value

Right Ventricular Functional Assessment
=======================================

Visual Assessment
-----------------

### I. What-to-see

1\. Evaluate the anatomy of the RV, right ventricular outflow tract (RVOT), global or regional wall motion, and wall thickness ([@B17]).2. Check for shunt flow, valvular stenosis, or regurgitation.3. Hemodynamic interactions between the LV and RV (e.g., constrictive physiology) may also be assessed.

### II. How-to

1\. Identify all cine images and determine whether the axis is distorted by using two different planes and whether the ventricle that you want to evaluate contains enough from the apex to the base at systole and diastole. Check for the presence of an artifact.2. Wall assessmentA. Evaluate global or regional wall motions and classify them as normokinetic, hypokinetic, or dyskinetic.B. If regional wall motion abnormality is observed, mention whether the location is the infundibulum, body, or apex.C. Measure the wall thickness at the atrial middle portion of the RV free wall in the ED phase (optional).

Quantitative Assessment
-----------------------

### I. What-to-see

1\. Evaluate ED volume, ES volume, EF, and SV of RV of both measured and BSA-indexed values ([@B23]).

### II. How-to

1\. Assess the contiguous stack of short-axis or transaxial cine images using analysis software ([Figs. 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). Transaxial cine images offer the best plane to identify the tricuspid valve plane and have good reproducibility. However, in clinical practice, the LV as well as RV are often assessed together and often evaluated by the short axis, known as the best plane for LV assessment ([@B24][@B25]).2. For accurate quantification, it is important to choose the ED and ES phases appropriately. Select the ED and ES phases when the RV size is the largest and smallest, respectively. This may be different from the ED and ES phases of the LV.3. When contouring the endocardial border, draw the inner boundary of the RVOT well and make it possible to include the pulmonary valve directly underneath. When contouring the basal slice, use at least two different planes to ensure that the RV cavity is well-contained. Trabeculae and papillary muscles are commonly included in the RV cavity, which contributes to reproducibility. This is different from the LV assessment method ([@B17]).4. In general, the RV mass is rarely evaluated, so the epicardial border is usually not drawn.5. LV assessment values can be used to validate the measured values, and if there is no intracardiac or extracardiac shunt, the LV and RV SVs are approximately the same.

### III. Pitfalls

1\. It is difficult to grasp the endocardial border around the RVOT and the pulmonary valve in both the transaxial and short-axis cine images, and it takes time to become skilled at doing this.2. It is difficult to distinguish whether the space seen in the basal slice of the short-axis cine is the RV or right atrium, reducing reproducibility. Therefore, it is recommended to refer to other planes as well ([Fig. 5](#F5){ref-type="fig"}).3. When there is a disease that can cause structural alteration of the RV (e.g., tricuspid regurgitation or pulmonary hypertension), the LV and RV axes are different from each other, and accurate assessment may be difficult with a short-axis cine. In this case, it is better to use the transaxial plane or to obtain the short-axis cine images for the RV axis again.

Reporting
---------

### I. Visual assessment

1\. EvaluationA. Sufficient/insufficient (if insufficient, describe below)1) Lack of image/insufficient FOV/artifact/etc. ( )2. Wall motionA. Global/septal/free wall (if present, describe location: )B. Normal/hypokinetic/dyskinetic3. Hemodynamic interaction between the RV and LVA. Present/absent4. Wall thickness (optional)A. Normal/thickened5. RV dilatation (optional)A. Present/absent

### II. Quantitative assessment

1\. MethodA. Short-axis/transaxial2. RV EF: %3. RV EDV: mL ( mL/m^2\*^)4. RV ESV: mL ( mL/m^2\*^)5. RV SV: mL ( mL/m^2\*^)6. RV CO: L/min7. RV CI: L/min/m^2\*\*^BSA-indexed value

Flow Imaging
============

Visual Assessment
-----------------

### I. What-to-see

1\. Blood flow directions in relation to cardiovascular anatomy.2. Accelerated flow jets associated with stenosis, valvular regurgitation, or shunting.

### II. How-to

1\. Display both magnitude and velocity map side-by-side using the stack or cine mode. If possible, also display the corresponding cine images (gradient echo or steady-state free precession).2. Check in- or through-plane acquisitions of the velocity map.3. The direction, dimensions and time courses of flow can provide useful information regarding disease etiology (e.g., abnormal flow jet in coarctation of the aorta \[[Fig. 6](#F6){ref-type="fig"}\], valvular regurgitation, or intracardiac shunt) ([@B26][@B27]).

### III. Pitfalls

1\. The flow jet may not be visualized if the velocity encoding (VENC) is set too high.2. A mosaic pattern on the image may be seen if the VENC is set too low ([@B28]).3. Echo time should be set as low as possible (3.5 ms or lower) for increased accuracy ([@B29]).

Quantitative Assessment
-----------------------

### I. What-to-see

1\. Directly measures the direction, volume, and velocity of blood flow in the blood vessel or heart.2. There are two kinds of parameters: directly calculated and secondarily derived.3. Directly calculated parameters include forward volume, reverse volume, and velocity (mean or peak).4. Derived parameters are as follows ([@B17]):A. Net volume (mL) = forward volume - reverse volumeB. Regurgitant fraction (%) = (reverse volume / forward volume) × 1005. In congenital heart disease or valve disease, hemodynamic information can be obtained using various flow parameters as follows ([Table 1](#T1){ref-type="table"}).

### II. How-to

1\. Display both magnitude and velocity maps side-by-side using a stack or cine mode.2. Make sure there are no aliasing artifacts (i.e., the VENC is too low) or low-contrast images (i.e., the VENC is too high) ([@B17]).3. Draw a line along the boundary of the blood vessel or heart structure to be measured on each phase or the magnitude image along whole-cardiac phases. Make sure that the noise outside the vessels or heart is not included.4. Baseline-correction can be applied in the software or using a phantom ([@B30][@B31]).

### III. Pitfalls

1\. Generally, the area of flow may be slightly larger than that drawn in the magnitude images.2. When reporting peak velocities, some pitfalls should be considered. First, the software package may have a different method of calculating the peak velocity (measuring one-pixel value vs. averaging several adjacent pixels). Second, if the imaging plane does not properly include the vena contracta, flow imaging will not reflect the true peak velocity. Third, the peak velocity from flow imaging can be underestimated, particularly at a lower spatial resolution.

MR Angiography
==============

Visual and Quantitative Assessments
-----------------------------------

### I. What-to-see

1\. Thoracic aorta: Aortic dimension, aortic wall irregularities, aortic wall thickness2. Pulmonary artery: Pulmonary arterial dimension, thrombi, wall irregularity3. Coronary artery: Degree of stenosis, origin or course of the coronary artery

### II. How-to

1\. Review multiplanar reformation (MPR), maximum intensity projection and volume-rendering images.2. Thoracic aortaA. The widest diameter is measured using a double-oblique MPR image perpendicular to the blood flow and measured at the standardized level ([@B32][@B33]).B. Measurements should preferably be done in the diastole phase.C. Describe wall irregularities, if present.D. Comparison between non-contrast and contrast-enhanced MR angiography is useful for evaluating vessel wall thickening or intramural thrombosis ([@B34]).3. Pulmonary artery and veinA. Measure the widest diameter perpendicular to the direction of blood flow.B. The pulmonary artery should be measured at the level of pulmonary bifurcation in the transaxial plane ([@B17][@B35][@B36]).4. Coronary arteryA. Describe anomalous origin or course of the coronary artery, if present.B. Stenosis extent: coronary artery stenosis of more than 50% is described as significant, and stenosis less than 50% as insignificant ([@B37]).

### III. Pitfall

1\. When measuring the sinus or sinotubular junction level of the aorta, electrocardiography-gating can be used to avoid under- or over-estimation ([@B17]).

Sample Report
=============

This following sample report was drawn from the consensus of members of the committee on CMR guidelines regarding diseases that are often indications for performing CMR in clinical practice. This sample report is not a set of guidelines to be followed by CMR practitioners. The authors intend to provide an example of the items included in the imaging protocol and a report for each disease. This sample report can be modified and adapted to each hospital and clinical situation.

Postoperative Tetralogy of Fallot
---------------------------------

History: Total correction state of TOF in 2009

Body weight, 34.6 kg; height, 138.6 cm; BSA, 1.15 m^2^.

Imaging protocols:

Scout, cine MRI (4-chamber, 2-chamber, 3-chamber, and short-axis); flow image (ascending aorta, descending aorta, superior vena cava, right pulmonary artery \[RPA\], left pulmonary artery \[LPA\], and main pulmonary artery); contrast-enhanced 3D MR angiography from the aortic arch to cardiac base; and delayed enhancement MRI (4-chamber, 2-chamber, 3-chamber, and short-axis) on a 1.5T scanner.

### I. Imaging findings ([Fig. 7](#F7){ref-type="fig"}):

1\. Morphological evaluation of cine MR, MR angiography, and delayed enhancement imagesA. Status post-total correction of TOFB. Unobstructed pulmonary arteries and aortaC. No evidence of obstruction or aneurysm in the RVOTD. Normal origin of the coronary arteryE. Small patchy delayed enhancement in the junction of the RV and LV.2. Ventricular function on cine MRIA. LV quantitative assessment1) Papillary muscle as ventricular cavity2) EF, 48.9%; EDV, 75.3 mL (65 mL/m^2\*^); ESV, 38.4 mL (33 mL/m^2\*^); SV, 36.8 mL^\*^BSA-indexed valueB. RV quantitative assessment1) Short-axis method2) RV EF, 37.7%; EDV, 131.3 mL (114 mL/m^2\*^); ESV, 81.8 mL (71 mL/m^2\*^); SV, 49.5 mL^\*^BSA-indexed value3. Flow quantification on flow MRIA. Flow volume: Ascending aorta, 34.0 mL; superior vena cava, 18.3 mL; descending aorta, 16.3 mLB. RPA, 22.3 mL (net volume); regurgitant fraction, 33.2%C. LPA, 13.0 mL (net volume); regurgitant fraction, 46.7%D. Main pulmonary artery, 33.3 mL (net volume); regurgitant fraction, 44.2%E. RPA + LPA, 35.3 mLF. Percentage of flow to the RPA and LPA---RPA:LPA = 63%:37%
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Supplementary Materials
=======================

The Data Supplement is available with this article at <https://doi.org/10.3348/kjr.2019.0407>.

###### Supplementary Movie Legends

**Movie 1.** Velocity map of a patient with coarctation of aorta.

![American Heart Association 17-segment model of LV myocardium.\
LV = left ventricle](kjr-20-1477-g001){#F1}

![LV quantitative assessment.\
For LV quantitative assessment, stack of short-axis slices containing entire LV is required, and endocardial (red) and epicardial (green) contours should be drawn in both diastole **(A)** and systole **(B)** phases. Inclusion or exclusion of papillary muscles should be mentioned. Note that papillary muscles are excluded in this example.](kjr-20-1477-g002){#F2}

![RV quantitative assessment with short-axis cine images.\
For RV quantitative assessment, stack of short-axis slices containing entire RV is required, and endocardial contour should be drawn in both diastole **(A)** and systole **(B)** phases. Generally, epicardial border is not drawn. RV = right ventricle](kjr-20-1477-g003){#F3}

![RV quantitative assessment with transaxial cine images.\
Endocardial contour in both diastole **(A)** and systole **(B)** phases is drawn in same way as for short-axis evaluation. Transaxial cine image offers best plane to identify tricuspid valve plane with good reproducibility.](kjr-20-1477-g004){#F4}

![Pitfall of RV short-axis evaluation: use different planes together.\
Short-axis evaluation of RV requires extra care in basal slice contouring, and it is helpful to use different planes together. Most basal slice (red line) is selected using 4-chamber cine images **(A, B)**, and endocardial contour is drawn in ED and ES phases. In ES phase, since valvular plane moves to apex (basal descent), endocardial contour that can be drawn in ED phase **(C)** may not be drawn in ES phase **(E)** at most basal slice. In addition, there may be different endocardial contour along valvular plane between ED **(D)** and ES phases **(F)**. ED = end-diastolic, ES = end-systolic, RA = right atrium](kjr-20-1477-g005){#F5}

![Case of 31-year-old man with coarctation of aorta.\
**A.** Contrast-enhanced MR angiography showing coarctation of aorta at isthmic portion of aorta. **B.** Velocity map crossing stenotic lesion showing flow acceleration (arrow) at coarctation site ([Supplementary Movie 1](#S1){ref-type="supplementary-material"}). **C.** Velocity map at level of AA. Because of low VENC value of 150 cm/s, aliasing artifact (arrowheads) occurred along wall of DA, just at distal portion of coarctation site. **D, E.** Time-flow volume curve maps showing change in flow volume along cardiac cycle. AA = ascending aorta, DA = descending aorta, VENC = velocity encoding](kjr-20-1477-g006){#F6}

![Images for postoperative tetralogy of Fallot sample report.](kjr-20-1477-g007){#F7}

###### List of Potentially Useful Flow Parameters Derived from Flow Imaging in Cases of Congenital Heart Disease or Valvular Heart Disease

![](kjr-20-1477-i001)

  Flow parameters                                                  Formulae
  ---------------------------------------------------------------- -----------------------------------------------------------------------
  Total systemic arterial flow (Qsa)                               Qao
  Total systemic venous return (Qsv)                               Qsvc + Qdao
  Total pulmonary arterial to total systemic arterial flow ratio   Qpa / Qsa
  Total pulmonary venous to total systemic venous flow ratio       Qpv / Qsv
  Total pulmonary arterial flow (Qpa)                              Qrpa + Qlpa
  Total pulmonary venous return (Qpv)                              Qrpv + Qlpv
  Systemic arterial flow to lungs (Qs - pa)                        Qpv - Qpa
  Systemic arterial flow to lungs^\*^ (Qs - pa^\*^)                Qao - Qdao - Qsvc
  Cardiac output (L/min)                                           (Net volume of Qsa or Qsv \[m\] x heart rate \[beats/minute\]) / 1000
  Cardiac index (L/min/m^2^)                                       Cardiac output / body surface area (m^2^)

^\*^Alternative formulae for same flow measurements. Qao = total aortic flow, Qdao = descending aortic flow, Qlpa = left pulmonary arterial flow, Qlpv = left pulmonary venous return, Qpa = total pulmonary arterial flow, Qpv = total pulmonary venous return, Qrpa = right pulmonary arterial flow, Qrpv = right pulmonary venous return, Qsa = total systemic arterial flow, Qsv = total systemic venous return, Qsvc = superior venous cava flow
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